|
|
||||||||



*
Institut für Anthropologie und Humangenetik, Ludwig-Maximilians-Universität München, Munich, Germany;
Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Regensburg, Germany; and
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037
The assembly of MHC Ia molecules in the endoplasmic reticulum
requires the presence of peptide ligands and ß2m
and is facilitated by chaperones in an ordered sequence of molecular
interactions. A crucial step in this process is the interaction of the
class I
-chain/ß2m dimer with TAP, which is believed
to ensure effective peptide loading of the empty class I molecule. We
have previously demonstrated impaired intracellular transport of the
class Ib molecule HLA-E in mouse myeloma cells cotransfected with the
genes for HLA-E and human ß2m, which is most likely
attributable to inefficient intracellular peptide loading of the HLA-E
molecule. We therefore analyzed the ability of HLA-E in the
transfectant cell line to bind synthetic peptides by means of their
ability to enhance cell surface expression of HLA-E. Peptide binding
was confirmed by testing the effect on the thermostability of soluble
empty HLA-E/human ß2m dimers. Two viral peptides binding
to HLA-E were thus identified, for which the exact positioning of the N
terminus appeared critical for binding, whereas the contribution of the
length of the C terminus seemed to be minor, allowing peptides as short
as seven amino acids and up to 16 amino acids to exhibit considerable
binding activity. Furthermore, we demonstrate that HLA-E interacts with
TAP and that this interaction can be prolonged by the proteasome
inhibitor
N-acetyl-L-leucyl-L-leucyl-L-norleucinal,
which reduces the intracellular peptide pool. The presented data
indicate that HLA-E is capable of presenting peptide ligands similar to
the repertoire of HLA class Ia molecules.
This article has been cited by other articles:
![]() |
M. Sensi, G. Pietra, A. Molla, G. Nicolini, C. Vegetti, I. Bersani, E. Millo, E. Weiss, L. Moretta, M. C. Mingari, et al. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5 Int. Immunol., March 1, 2009; 21(3): 257 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lo Monaco, L. Sibilio, E. Melucci, E. Tremante, M. Suchanek, V. Horejsi, A. Martayan, and P. Giacomini HLA-E: Strong Association with {beta}2-Microglobulin and Surface Expression in the Absence of HLA Class I Signal Sequence-Derived Peptides J. Immunol., October 15, 2008; 181(8): 5442 - 5450. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Coupel, A. Moreau, M. Hamidou, V. Horejsi, J.-P. Soulillou, and B. Charreau Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation Blood, April 1, 2007; 109(7): 2806 - 2814. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Barel, N. Pizzato, P. Le Bouteiller, E. J. H. J. Wiertz, and F. Lenfant Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation Int. Immunol., January 1, 2006; 18(1): 173 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Wooden, S. R. Kalb, R. J. Cotter, and M. J. Soloski Cutting Edge: HLA-E Binds a Peptide Derived from the ATP-Binding Cassette Transporter Multidrug Resistance-Associated Protein 7 aSnd Inhibits NK Cell-Mediated Lysis J. Immunol., August 1, 2005; 175(3): 1383 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Kaiser, F. Barahmand-pour, W. Paulsene, S. Medley, D. E. Geraghty, and R. K. Strong Interactions between NKG2x Immunoreceptors and HLA-E Ligands Display Overlapping Affinities and Thermodynamics J. Immunol., March 1, 2005; 174(5): 2878 - 2884. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nattermann, H. D. Nischalke, V. Hofmeister, G. Ahlenstiel, H. Zimmermann, L. Leifeld, E. H. Weiss, T. Sauerbruch, and U. Spengler The HLA-A2 Restricted T Cell Epitope HCV Core35-44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer Cells Am. J. Pathol., February 1, 2005; 166(2): 443 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pietra, C. Romagnani, P. Mazzarino, M. Falco, E. Millo, A. Moretta, L. Moretta, and M. C. Mingari HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes PNAS, September 16, 2003; 100(19): 10896 - 10901. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Miller, D. A. Weber, C. Ibegbu, J. Pohl, J. D. Altman, and P. E. Jensen Analysis of HLA-E Peptide-Binding Specificity and Contact Residues in Bound Peptide Required for Recognition by CD94/NKG2 J. Immunol., August 1, 2003; 171(3): 1369 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Strong, M. A. Holmes, P. Li, L. Braun, N. Lee, and D. E. Geraghty HLA-E Allelic Variants. CORRELATING DIFFERENTIAL EXPRESSION, PEPTIDE AFFINITIES, CRYSTAL STRUCTURES, AND THERMAL STABILITIES J. Biol. Chem., February 7, 2003; 278(7): 5082 - 5090. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Romagnani, G. Pietra, M. Falco, E. Millo, P. Mazzarino, R. Biassoni, A. Moretta, L. Moretta, and M. C. Mingari Identification of HLA-E-specific alloreactive T lymphocytes: A cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells PNAS, August 20, 2002; 99(17): 11328 - 11333. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Kraft, R. E. Vance, J. Pohl, A. M. Martin, D. H. Raulet, and P. E. Jensen Analysis of Qa-1bPeptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1-Peptide Complexes J. Exp. Med., September 5, 2000; 192(5): 613 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Wainwright, P. A. Biro, and C. H. Holmes HLA-F Is a Predominantly Empty, Intracellular, TAP-Associated MHC Class Ib Protein with a Restricted Expression Pattern J. Immunol., January 1, 2000; 164(1): 319 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Toomey, M. Salcedo, L. A. Cotterill, M. M. Millrain, Z. Chrzanowska-Lightowlers, J. Lawry, K. Fraser, F. Gays, J. H. Robinson, S. Shrestha, et al. Stochastic Acquisition of Qa1 Receptors During the Development of Fetal NK Cells In Vitro Accounts in Part But Not in Whole for the Ability of These Cells to Distinguish Between Class I-Sufficient and Class I-Deficient Targets J. Immunol., September 15, 1999; 163(6): 3176 - 3184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Martinozzi, R. Pacasova, H.-J. Boulouis, M. Ulbrecht, E. H. Weiss, F. Sigaux, and M. Pla Cutting Edge: Requirement of Class I Signal Sequence-Derived Peptides for HLA-E Recognition by a Mouse Cytotoxic T Cell Clone J. Immunol., May 15, 1999; 162(10): 5662 - 5665. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-F. Lo, H. Ong, E. S. Metcalf, and M. J. Soloski T Cell Responses to Gram-Negative Intracellular Bacterial Pathogens: A Role for CD8+ T Cells in Immunity to Salmonella Infection and the Involvement of MHC Class Ib Molecules J. Immunol., May 1, 1999; 162(9): 5398 - 5406. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Brooks, F. Borrego, P. E. Posch, A. Patamawenu, C. J. Scorzelli, M. Ulbrecht, E. H. Weiss, and J. E. Coligan Specific Recognition of HLA-E, But Not Classical, HLA Class I Molecules by Soluble CD94/NKG2A and NK Cells J. Immunol., January 1, 1999; 162(1): 305 - 313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |